Heloisa Zaccaron Milioli
Biography
Dr Heloisa Helena Milioli completed her PhD from the University of Newcastle (UoN) in 2017 and pursued a postdoctoral training with A/Prof Elgene Lim at the Connie Johnson Breast Cancer Research Laboratory, Garvan Institute of Medical Research. She was awarded the Cancer Institute of NSW Early-Career Fellowship (2018 – 2020) to study the interplay between sex steroid hormone receptors in cancer, with particular emphasis on novel therapeutic strategies for endocrine-resistant breast cancers.
Dr Heloisa Helena Milioli completed her PhD from the University of Newcastle (UoN) in 2017 and pursued a postdoctoral training with A/Prof Elgene Lim at the Connie Johnson Breast Cancer Research Laboratory, Garvan Institute of Medical Research. She was awarded the Cancer Institute of NSW Early-Career Fellowship (2018 – 2020) to study the interplay between sex steroid hormone receptors in cancer, with particular emphasis on novel therapeutic strategies for endocrine-resistant breast cancers.
Awards and Honours
2018 – 2020 CINSW Early Career Fellowship, Cancer Institute NSW – Australia
2012 – 2017 UNIPRS/UNRSC Scholarship, The University of Newcastle – Australia
2009 – 2011 REUNI/Capes Scholarship, Universidade Federal do Parana – Brazil
GRANTS
2018 Garvan Institute of Medical Research Travel Grant. EMCR Forum - Science Pathways 2018: Diversify your Thinking –Australia
2016 EMBL Australia PhD Travel Grant (AUD $3,000) - EMBL travel grant to attend the 18th EMBL PhD Symposium – Australia
2015 HCRA PhD RESEARCH AWARD 2016 (AUD $5,000) - Hunter Cancer Research Alliance (HCRA) – Newcastle NSW, Australia
2015 Bioinfosummer 2015 Travel Bursary (AUD $500) - Australian Mathematical Sciences Institute (AMSI), Australia
2015 HCRA TRAVEL GRANT (AUD $1,000) - Hunter Cancer Research Alliance (HCRA) – Newcastle NSW, Australia
2014 JENNIE THOMAS MEDICAL RESEARCH TRAVEL GRANT (AUD $10,000) - Hunter Medical Research Institute – Newcastle NSW, Australia.
AWARDS
2016 - Young Scientist Award, 2nd World Congress on Controversies in Breast Cancer (CoBrCA). Barcelona, ES
2015 - Best Poster Award, BioInfoSummer. Sydney NSW, AU.
2014 - Best Poster Presentation, BioInfoSummer, 2014. Melbourne VIC, AU.
2014 - Best Poster Award, International Conference on Bioinformatics (InCoB). Sydney NSW, AU.
Education
2011 – Master in Genetics
2008 – Bachelor in Biological Sciences
Selected Publications
MILIOLI, H.H.; TISHCHENKO, I.; RIVEROS, C.; BERRETTA, R.; MOSCATO, P. (2017) Basal-like breast cancer: molecular profiles, clinical features and survival outcomes. BMC Med Genomics; 10(1):19. doi: 10.1186/s12920-017-0250-9.
MILIOLI, H.H.; VIMIEIRO, R.; TISHCHENKO, I.; RIVEROS, C.; BERRETTA, R.; MOSCATO, P. (2016) Iteratively refining breast cancer intrinsic subtypes in the METABRIC dataset, BioData Mining; 9:2. doi: 10.1186/s13040-015-0078-9
MILIOLI, H.H. (2016) Life as an early career researcher: interview with Heloisa Helena Milioli. Future Science OA; 1(4). doi: 10.4155/fsoa-2016-0033
TISHCHENKO, I.; MILIOLI, H.H.; RIVEROS, C.; MOSCATO, P. (2016) Extensive Transcriptomic and Genomic Analysis Provides New Insights about Luminal Breast Cancers. PLoS ONE 11(6): e0158259. doi: 10.1371/journal.pone.0158259
OLIVEIRA, N.C.S; GOMIG, T.H.B.; MILIOLI, H.H.; CORDEIRO, F.; COSTA, G.G.; URBAN, C.A.; LIMA, R.S.; CAVALLI, I.J.; RIBEIRO, E.M.S.F. (2016) Comparative proteomic analysis of ductal and lobular invasive breast carcinoma. Genetics and Molecular Research; 15(2). doi: 10.4238/gmr.15027701
MILIOLI, H.H. The IMPAKT of breast cancer research: fundamental science and clinical medicine. (2015) Future Science OA; 1(4). doi: 10.4155/fso.15.69
MILIOLI, H.H.; VIMIEIRO, R.; RIVEROS, C.; TISHCHENKO, I.; BERRETTA, R.; MOSCATO, P. (2015) The discovery of novel biomarkers improves breast cancer intrinsic subtype prediction and reconciles the original PAM50 labels in the METABRIC data set. PLoS ONE; 10(7):0129711. doi: 10.1371/journal.pone.0129711
MILIOLI, H.H.; SOUSA, K; KAVISKI, R.; OLIVEIRA, N.C.S.; URBAN, C.A.; LIMA, R.S.; CAVALLI, I.J.; RIBEIRO, E.M.S.F. (2015) Comparative proteomics of primary breast carcinomas and lymph node metastases outlining markers of tumour invasion. Cancer Genomics and Proteomics; 12(2):89-101.
